Tepmetko Tablet
Product Images NDC 44087-5000

3 FDA label images from Emd Serono, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tepmetko (NDC 44087-5000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tepmetko 01)

Chemical Structure (Tepmetko 01)
Chemical structure diagram of the active ingredient tepotinib hydrochloride, showing its molecular arrangement including multiple aromatic rings, nitrogen-containing heterocycles, and a morpholine ring with associated water (H2O) and hydrochloride (HCl) components.*
FDA Label Image

Principal Display Panel (30 Tablet Blister Pack Carton)

Principal Display Panel (30 Tablet Blister Pack Carton)
TEPMETKO (tepotinib) tablets, 225 mg per tablet, oral dosage form. The label shows a carton containing 30 tablets divided into 3 child-resistant blister cards of 10 tablets each. The product is labeled as prescription-only and is manufactured by EMD Serono, Inc. The NDC is 44087-5000-3.*
FDA Label Image

Principal Display Panel (60 Tablet Blister Pack Carton)

Principal Display Panel (60 Tablet Blister Pack Carton)
TEPMETKO 225 mg tablets containing tepotinib, oral dosage form. The label states each tablet contains 225 mg of tepotinib (equivalent to 250 mg tepotinib hydrochloride hydrate). The carton includes 6 child resistant blister cards with 10 tablets each, totaling 60 tablets. Labeler is EMD Serono, Inc., with NDC 44087-5000-6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.